Skip to main content
Clinical Trials/NCT01436253
NCT01436253
Completed
Not Applicable

Non-Interventional Study In Hyperlipidemic Patients Who Do Not Reach Satisfactory Lipid Values With Existing Hypolipemic Therapy

Organon and Co0 sites2,196 target enrollmentDecember 2008

Overview

Phase
Not Applicable
Intervention
Lifestyle Changes
Conditions
Dyslipidemia
Sponsor
Organon and Co
Enrollment
2196
Primary Endpoint
Percentage of Participants Achieving Target Lipid Values
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study is being done to see whether dietary and medicinal measures compliant with hyperlipidemia treatment guidelines will result in achieving target lipid values and to evaluate the total risk of cardiovascular disease in study participants who have not reached satisfactory lipid levels with their current hypolipemic therapy.

Registry
clinicaltrials.gov
Start Date
December 2008
End Date
February 2013
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Croatian participants with hyperlipidemia

Participants being treated in a physician's office for hyperlipidemia who have not achieved target lipid levels on their current hypolipemic therapy.

Intervention: Lifestyle Changes

Croatian participants with hyperlipidemia

Participants being treated in a physician's office for hyperlipidemia who have not achieved target lipid levels on their current hypolipemic therapy.

Intervention: Hypolipemics

Outcomes

Primary Outcomes

Percentage of Participants Achieving Target Lipid Values

Time Frame: Baseline and Month 3

Target total cholesterol value was \<4.5 mmol/L and target low densisty lipoprotein (LDL) value was \<2.5 mmol/L

Percentage of Participants With Reduced Cardiovascular Risk

Time Frame: Baseline and Month 3

Cardiovascular risk assessment to determine the 10-year risk for developing cardiovascular disease was done using Framingham risk scoring; categories scored are age, high density lipoprotein (HDL) cholesterol value, total cholesterol value, history of cigarette smoking, and systolic blood pressure. The total of all the points for each risk factor is used to assign a percentage of risk for the occurence of cardiovascular disease within 10 years. Total points for men range from -9 to +37 and for women from -8 to +46; \>=17 total points for men, and \>=25 total points for women indicates a \>=30% risk of developing cardiovascular disease.

Similar Trials